liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma
Martin-Luther University of Halle-Wittenberg, Germany.
Martin-Luther University of Halle-Wittenberg, Germany.
Martin-Luther University of Halle-Wittenberg, Germany.
Martin-Luther University of Halle-Wittenberg, Germany.
Show others and affiliations
2005 (English)In: Surgery, ISSN 0039-6060, E-ISSN 1532-7361, Vol. 138, no 6, 986-993 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Hepatic metastases from medullary thyroid carcinoma (MTC) may impair quality of life by hypercalcitonemia-associated diarrhea and pain. In this prospective study, the effect of selective arterial chemoembolization (SACE) was evaluated.

METHODS: Eleven patients with hepatic metastases from MTC received 1 to 9 courses of SACE using epirubicine. Symptomatic, biochemical, and morphologic responses on SACE were recorded.

RESULTS: Symptomatic response was observed in all symptomatic patients. However, biochemical and radiologic response occurred only in 6 patients. Liver function was not affected by SACE. One patient with unexpected concurrent pheochromocytoma metastases died after the first course. Development of side effects in the course was observed in 8 patients but were only World Health Organization grade 1. Patients' satisfaction with SACE was excellent. Long-term follow-up found 7 patients alive (1-72 months). Three patients died with tumor 6, 12, and 24 months after SACE, respectively.

CONCLUSION: SACE provided good symptom palliation for the majority of patients with hepatic metastases from MTC. However, transient remission or stabilization of hepatic metastases resulted in only 60%. Further studies using a randomized protocol are required.

Place, publisher, year, edition, pages
Elsevier, 2005. Vol. 138, no 6, 986-993 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-101422DOI: 10.1016/j.surg.2005.09.020PubMedID: 16360382OAI: oai:DiVA.org:liu-101422DiVA: diva2:666179
Note

Discussion page 993

Available from: 2013-11-22 Created: 2013-11-22 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Gimm, Oliver

Search in DiVA

By author/editor
Gimm, Oliver
In the same journal
Surgery
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 42 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf